ICN Phramceuticals, Inc, f

CoolTouch Nd:YAG Laser System K O A 2 4 (2 0; ~

Page 13 .

ICN Pharmaceuticals, Inc.
CoolTouch Nd:YAG Laser System
510(k) Premarket Notification NOV 22 2002
$100k} SUMMARY

Submitter: ICN Pharmaceuticals, Inc.

Address: 3300 Hyland Ave.
Costa Mesa, CA 92626

Contact Person: Edward F. Smith I
Director, Corporate Regulatory Affairs

Telephone: (714) 545-0100 X 2016

Facsimile: (714) 641-7241

Date Prepared: August 22, 2002

Device Trade Name: CoolTouch Nd:YAG Laser System
CoolTouch-II Nd:YAG Laser System

Common Name: Nd: YAG Pulsed Surgical Laser

Classification Name: Laser Surgical Instrument.
21 CFR. § 878.4810 ,

Legally Marketed Predicate Device: New Star Lasers, Inc. Model 130 Nd:YAG Surgical
Laser System (K962791).

Description of the CoolTouch The CoolTouch Nd:YAG Laser Systems are ND:YAG

Nd:YAG Laser Systems: lasers producing laser emission at 1320 nm. The lasers
consist of three interconnected sections: The cabinet,
which houses the power supply, cooling system,
microcontroller and the laser, the fiber optic, and the
handpiece.

Intended use of CoolTouch The CoolTouch Nd:YAG Laser Systems are indicated

Nd:YAG Laser Systems: for use in Dermatological and Plastic Surgery
applications including use in the treatment of fine lines
and wrinkles.

Nonclinical Performance Data: None

Clinical Performance Data: Clinical trials produced results that indicated that the
CoolTouch Nd:YAG Laser Systems are effective m the
treatment of periorbital and perioral wrinkles. See
previous related $10(k) submissions for clinical results.

Conclusion: The CoolTouch Nd:YAG Laser Systems are indicated

13

ICN Phramceuticals, inc. UY; 2X
. CooiTouch Nd:YAG Laser System Ic 6 2 ? vA { )
Page 14 .
for the general treatment of wrinkles.
Additional Information: None requested at this time
. 14

i ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES : Public Health Service
a - * Oo . : : , : Food and Drug Administration
an NOV 2:2 2002 -Rodkite MD 20860
ICN Pharmaceuticals, Inc. . : o
: Dr. Edward F. Smith TIE / oo oo a
. ° Director, Corporate Regulatory Affairs co, Do. .
: 3300 Hyland Avenue ,
Costa Mesa, California 92626 . . :
Re: K022817 ,
Trade/Device Name: CoolTouch Nd: YAG and CoolTouch I] Nd: YAG Laser Systems
Regulation Number: 878.4810
Regulation Name: Laser surgical instrument
Regulatory Class: Class II
Product Code: GEX
Dated: August 22, 2002
Received: August 26, 2002
Dear Dr. Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part
807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the

7 Page 2 — Dr, Edward F. Smith De :
“+ iguality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product -.
radiation control provisions (Sections'531-542 of the Act); 21 CFR 1000-1050. — ‘ : This letter will allow you to begin marketing your device as described in your Section 510(k)
Se ptemarket notification. The FDA finding of substantial equivalence of your device to a legally
— a marketed predicate device results in a classification for your device and thus, permits your device °
: to proceed to the market. © : - . : a , ,
' If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
: contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion
and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also,
please note the regulation entitled, "Misbranding by reference to premarket notification” (21CFR
Part 807.97). Other general information on your responsibilities under the Act may be obtained
from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free
number (800) 638-2041 or (301) 443-6597 or at its Internet address /
http: //www. fda.gov/cdrh/dsma/dsmamain. html
Sincerely yours,
muuam C Bove
&tcelia M. Witten, Ph.D., MD
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

Oo ICN Phrameeuticals, Inc. se oo cs BS .
Coo]Touch Nd:YAG Laser System
: : Page 23 - : . :
- INDICATION FOR USE STATEMENT an
510(k) Number: ___ K022817 , —
Device Name: ICN Pharmaceuticals, Inc. “CoolTouch” and “CoolTouch-D”
Nd:YAG Laser Systems
Indications for Use:
The CoolTouch Nd:YAG Laser Systems are indicated for use in Dermatological
and Plastic Surgery applications including use in the treatment of fine lines and
wrinkles.
(Please do not write below this line - Continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
. . ok 1

uiaml Povest

(Division Sign-Off) .

Division of General, Restorative

and Neurological Devices

0 2av)
Prescription Use /: 10(k) Numbg KO BACT Use
(per 21 CFR 801.109)
23

